Medication info
Apito Tablet (Atorvastatin Calcium Trihydrate)

Apito Tablet (Atorvastatin Calcium Trihydrate)

Prescription medicationTabletOral
Ingredient · strength
Atorvastatin Calcium Trihydrate›10.85mg / 1 tablet
Manufacturer / importer
NexPharm Korea Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201210138 · Approved 2012.12.17 · Insurance code 662502740

Summary

Main use
Improvement of hyperlipidemia in adults and children; prevention of cardiovascular diseases (such as myocardial infarction and stroke)
Who takes it
Adults · Children
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be started at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or after dose titration, and the dose should be adjusted accordingly. Because the treatment goal is to reduce LDL cholesterol, measurement of LDL cholesterol is recommended when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or use this medicine when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients 70 years of age and older are generally similar to those in the general adult patient population.
Child dose
Pediatric patients (10 ∼ 17 years of age) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg per day of this medicine, and the recommended maximum dose is 20 mg per day (there are no clinical data on administering doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Ingredients

Manufacturer
NexPharm Korea Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia in adults and children; prevention of cardiovascular diseases (such as myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • vascular surgery
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • type 2 diabetes
  • congestive heart failure
  • angina
  • hypercholesterolemia
View approved original text

This medication helps to reduce the risk of cardiovascular diseases. Specifically, it lowers the risks of myocardial infarction and stroke, as well as reducing the risk of complications from angina and vascular surgery. In patients with hyperlipidemia, it effectively lowers total cholesterol and bad LDL cholesterol levels, while increasing good HDL cholesterol levels. Additionally, it is used as an adjunct to diet to reduce total cholesterol and LDL cholesterol in pediatric patients with heterozygous familial hypercholesterolemia, contributing to a decrease in the risk of cardiovascular diseases. Therefore, this drug is effectively used for the management of cardiovascular diseases and hyperlipidemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be started at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or after dose titration, and the dose should be adjusted accordingly. Because the treatment goal is to reduce LDL cholesterol, measurement of LDL cholesterol is recommended when initiating treatment and evaluating the treatment response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or use this medicine when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL-cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Older adults: The efficacy and safety in patients 70 years of age and older are generally similar to those in the general adult patient population.

Child dose

Pediatric patients (10 ∼ 17 years of age) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg per day of this medicine, and the recommended maximum dose is 20 mg per day (there are no clinical data on administering doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle-related symptoms; if severe muscle pain or weakness occurs, stop taking the medication immediately and consult a doctor. Patients with liver function problems or abnormally high liver enzyme levels should not take this medication and must undergo regular liver function tests while using it. Women who are pregnant or may become pregnant should not take this medication and must use effective contraception during treatment. This drug may interact with specific medications, so inform your doctor or pharmacist about any other medications you are currently taking. Patients who excessively consume alcohol or have a history of liver disease should take this medication with caution and should consult medical personnel immediately if abnormal symptoms occur. Children, especially those under 10 years old, should not use this medication, while adolescents aged 10 and older should take it according to a doctor's advice. Elderly patients are at higher risk for muscle-related side effects, so they need to be cautious while taking it, and regular check-ups and symptom observations are necessary. During the period of taking this medication, if symptoms such as muscle pain, weakness, or fever appear, notify a doctor immediately. In particular, if muscle pain becomes severe or persists, a blood test should be performed to check for muscle damage. This medication contains lactose; therefore, patients with lactose intolerance should not take it. In case of overdose, there is no specific antidote; appropriate treatment should be received based on symptoms, and it should be stored in a safe place out of reach of children.

Side effects

  • Weakness
  • fatigue
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 163 more
  • loss of appetite
  • constipation
  • abdominal distension
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngalgia
  • laryngalgia
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • dysgeusia
  • memory loss
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • thrombocytopenia
  • vasculitis
  • allergic reaction
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • elevated cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • elevated serum ALT levels
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial distress
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory disturbances
  • vertigo
  • photosensitivity reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinesia
  • depression
  • tension
  • muscular diseases
  • arthritis
  • mucous cystitis
  • tenosynovitis
  • myasthenia gravis
  • contractures
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast hypertrophy
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypothermia
  • hyperlipidemia
  • facial flushing
  • non-protein nitrogen increase
  • hyperuricemia
  • gingival hypertrophy
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • cognitive impairment
  • severe muscular weakness
  • ocular myasthenia
  • elevated AST

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air or moisture. It is important to maintain the storage temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.